Search

Search Constraints

You searched for: Author/Creator Hoos, Axel

Search Results

1. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. Issue 5 (May 2015)

2. Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study. Issue 2 (February 2020)

3. Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma. (17th June 2013)

4. First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1). Issue 3 (16th March 2023)

5. Immunodynamics of explanted human tumors for immuno‐oncology. Issue 1 (29th December 2020)

8. Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial. Issue 12 (December 2018)